Neuroglobin: A New Possible Marker of Estrogen-Responsive Breast Cancer

The expression of the α-subtype of Estrogen Receptor (ERα) characterizes most breast cancers (more than 75%), for which endocrine therapy is the mainstay for their treatment. However, a high percentage of ERα+ breast cancers are de novo or acquired resistance to endocrine therapy, and the definition...

Descripción completa

Detalles Bibliográficos
Autores principales: Solar Fernandez, Virginia, Fiocchetti, Marco, Cipolletti, Manuela, Segatto, Marco, Cercola, Paolo, Massari, Annalisa, Ghinassi, Sabrina, Cavaliere, Francesco, Marino, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393432/
https://www.ncbi.nlm.nih.gov/pubmed/34440755
http://dx.doi.org/10.3390/cells10081986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393432/
https://www.ncbi.nlm.nih.gov/pubmed/34440755
http://dx.doi.org/10.3390/cells10081986

Ejemplares similares